Table 1.

Univariate analysis for overall survival (OS)

^*RT target is curative when all grossly visible lesions are included or palliative when part of the visible lesions are included; ^†Response was evaluated 1 month after SABR using modified RECIST criteria. Responder means complete response and partial response. Nonresponder means stable disease and progressive disease; ^‡Twenty patients received additional treatment after SABR. ECOG, Eastern Cooperative Oncology Group; CP, Child-Pugh; BCLC, Barcelona Clinic Liver Cancer; VI, vascular invasion; EHM, extrahepatic metastases; MPVTT, main portal vein tumor thrombosis; BED, biologically equivalent dose.